TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT)TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT)TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT)

TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT)

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪1.83 B‬USD
−1.94USD
‪−222.61 M‬USD
‪747.72 M‬USD
‪65.16 M‬
Beta (1Y)
1.79
Employees (FY)
‪2.4 K‬
Change (1Y)
−200 −7.69%
Revenue / Employee (1Y)
‪311.55 K‬USD
Net income / Employee (1Y)
‪−92.75 K‬USD

About Tandem Diabetes Care, Inc.


CEO
John F. Sheridan
Headquarters
San Diego
Founded
2006
FIGI
BBG00M59W3C1
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its products include Tandem Mobi System and t:slim X2 Insulin Pump. The company was founded by Paul M. DiPerna on January 27, 2006, and is headquartered in San Diego, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 0M0F is 30.18 USD — it has increased by 4.62% in the past 24 hours. Watch TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT) stocks are traded under the ticker 0M0F.
0M0F stock has fallen by −7.12% compared to the previous week, the month change is a −18.42% fall, over the last year TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT) has showed a 64.74% increase.
We've gathered analysts' opinions on TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT) future price: according to them, 0M0F price has a max estimate of 75.00 USD and a min estimate of 18.00 USD. Watch 0M0F chart and read a more detailed TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT) stock forecast: see what analysts think of TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT) and suggest that you do with its stocks.
0M0F reached its all-time high on Dec 22, 2021 with the price of 152.17 USD, and its all-time low was 13.89 USD and was reached on Nov 10, 2023. View more price dynamics on 0M0F chart.
See other stocks reaching their highest and lowest prices.
0M0F stock is 7.63% volatile and has beta coefficient of 1.79. Track TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT) stock price on the chart and check out the list of the most volatile stocks — is TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT) there?
Today TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT) has the market capitalization of ‪1.98 B‬, it has increased by 5.46% over the last week.
Yes, you can track TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT) financials in yearly and quarterly reports right on TradingView.
TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT) is going to release the next earnings report on Feb 19, 2025. Keep track of upcoming events with our Earnings Calendar.
0M0F earnings for the last quarter are −0.35 USD per share, whereas the estimation was −0.41 USD resulting in a 14.06% surprise. The estimated earnings for the next quarter are −0.21 USD per share. See more details about TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT) earnings.
TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT) revenue for the last quarter amounts to ‪242.93 M‬ USD, despite the estimated figure of ‪224.14 M‬ USD. In the next quarter, revenue is expected to reach ‪249.81 M‬ USD.
0M0F net income for the last quarter is ‪−23.25 M‬ USD, while the quarter before that showed ‪−30.81 M‬ USD of net income which accounts for 24.54% change. Track more TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT) financial stats to get the full picture.
No, 0M0F doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has ‪2.40 K‬ employees. See our rating of the largest employees — is TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT) on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT) EBITDA is ‪−117.21 M‬ USD, and current EBITDA margin is −18.56%. See more stats in TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT) financial statements.
Like other stocks, 0M0F shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT) technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT) stock shows the sell signal. See more of TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.